Cargando...
Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1
Oncolytic viruses are potent anticancer agents that replicate within and kill cancer cells rather than normal cells, and their selectivity is largely determined by oncogenic mutations. M1, a novel oncolytic virus strain, has been shown to target cancer cells, but the relationship between its cancer...
Gardado en:
| Publicado en: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7718955/ https://ncbi.nlm.nih.gov/pubmed/33037696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12820 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|